Skip to Main Content

Author Details

Boris Winterhoff
University of Minnesota
2008
53
28
PMIDPaper TitleJournal TitlePublished Year
37541199Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.Cell2023
35380877The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.Sci Signal2022
34339033Single-Cell RNA Sequencing of Ovarian Cancer: Promises and Challenges.Adv Exp Med Biol2021
34642026Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer.Gynecol Oncol2021
31527166Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer.Clin Cancer Res2020
31851045Molecular characterization of endometrial cancer and therapeutic implications.Curr Opin Obstet Gynecol2020
32747365Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma.Cancer Res2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32360360Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer.Biochem Pharmacol2020
30507624Molecular characterization of endometrial cancer and therapeutic implications.Curr Opin Obstet Gynecol2019
31328624UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTs.Cancer Biol Ther2019
31266885De novo prediction of cell-type complexity in single-cell RNA-seq and tumor microenvironments.Life Sci Alliance2019
30718125A patient-centered mobile health application to motivate use of genetic counseling among women with ovarian cancer: A pilot randomized controlled trial.Gynecol Oncol2019
30507625Single-cell sequencing in ovarian cancer: a new frontier in precision medicine.Curr Opin Obstet Gynecol2019
30815151Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions.AMIA Annu Symp Proc2018
30097329Corrigendum to "Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells" [Gyncol. Oncol. 144 (2017) 598-606].Gynecol Oncol2018
27887804The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial.Gynecol Oncol2017
28111004Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells.Gynecol Oncol2017
28159814Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.Clin Cancer Res2017
28395052Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed.Am J Clin Pathol2017
28805821Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.Nat Med2017
28041631Targeting fibroblast growth factor pathways in endometrial cancer.Curr Probl Cancer2017
27941362Molecular characterization of endometrial cancer and therapeutic implications.Curr Opin Obstet Gynecol2017
25893298Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.Oncogene2016
27121063USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.Oncotarget2016
27253175Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer.Br J Cancer2016
27016234Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures.Gynecol Oncol2016
26827964Gene-expression signatures in ovarian cancer: Promise and challenges for patient stratification.Gynecol Oncol2016
25378557Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.Hum Mol Genet2015
25986173Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.BMC Cancer2015
25754234PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples.Eur J Cancer2015
25487306Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.Hum Genet2015
24728075Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer.Cancer Res2014
25269487Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer.J Natl Cancer Inst2014
25106938Markers of cellular senescence are elevated in murine blastocysts cultured in vitro: molecular consequences of culture in atmospheric oxygen.J Assist Reprod Genet2014
24504028Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status.Sci Rep2014
22899400Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.J Pathol2013
23729402Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer.Mol Cancer Ther2013
23781004L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.J Natl Cancer Inst2013
23443805Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.Mol Cancer Ther2013
23382860Inherited variants in regulatory T cell genes and outcome of ovarian cancer.PLoS One2013
23535731Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet2013
23535730GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.Nat Genet2013
23535648Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.Nat Commun2013
23535649Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.Nat Commun2013
23571109Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.Hum Mol Genet2013
22364882Characterisation of FAP-1 expression and CD95 mediated apoptosis in the A818-6 pancreatic adenocarcinoma differentiation system.Differentiation2012
22221703HMGA gene rearrangement is a recurrent somatic alteration in polypoid endometriosis.Hum Pathol2012
21278246Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.Clin Cancer Res2011
  • 1 - 50 of 53

Recommended Authors

Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 8
Kaiyang Zhang
University of Helsinki
Career Start Year 2017
Number of shared co-authors 8
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 2
Yukie Bean
Oregon Health & Science University
Career Start Year 2013
Number of shared co-authors 110
Francis Nguyen
Ontario Institute for Cancer Research
Career Start Year 2012
Number of shared co-authors 1
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 11
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 4
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 1
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 5
Yovanni Casablanca
Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
Career Start Year 2007
Number of shared co-authors 60
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 2
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 32
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 46
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Career Start Year 2004
Number of shared co-authors 41
Dariush Etemadmoghadam
Peter MacCallum Cancer Centre
Career Start Year 2004
Number of shared co-authors 28
Karin Jirstr??m
Lund University
Career Start Year 2003
Number of shared co-authors 4
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 2
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 15
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 32
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 20
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 1
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 9
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 7
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 9
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 1
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 25
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 64
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 34
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 55

Collaborators

Gottfried E Konecny
David Geffen School of Medicine at University of California Los Angeles
Co-authored papers 27
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 16
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 12
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 11
Melissa C Larson
Mayo Clinic
Co-authored papers 10
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 10
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 9
Sebastian M Armasu
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 8
Stefan Kommoss
Eberhard Karls University Tubingen
Co-authored papers 8
Andrew Berchuck
Duke School of Medicine
Co-authored papers 8
Gary L Keeney
Mayo Clinic
Co-authored papers 8
Dennis J Slamon
David Geffen School of Medicine at university of california los angeles
Co-authored papers 8
Honglin Song
University of Cambridge
Co-authored papers 8
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 8
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 8
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 7
Mine S Cicek
Mayo Clinic
Co-authored papers 7
Jonathan Tyrer
Co-authored papers 7
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 7
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 7
Andreas du Bois
Co-authored papers 6
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 6
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 6
Graham G Giles
Co-authored papers 6
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 6
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 6
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 6
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 6
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 6
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 6
Release 1.2